AusBiotech Global Investment Series

The AusBiotech-led Asian Investment Series confirmed that investor interest in the Australian life science industry is strong and intensifying.

Almost 400 delegates gathered to hear 21 Australian biotechnology and medical technology companies present their investment proposition as part of the Series, which was held in Singapore, Hong Kong and Shanghai during March.

AusBiotech CEO, Glenn Cross, who led the three events, said: "This strong investor interest in the Australian life sciences stems from the nation's top ranking in the global life sciences and its diverse suite of investment opportunities in biotechnology and pharmaceuticals."

Read the article, Asian Investor series confirms strong investor interest.

The events featured:

  • Biotech and medtech company spotlight presentations
  • Networking sessions
  • A business matching program to set up one-on-one meetings
  • Well-researched, high-quality program that covers relevant trends in biotech investment globally
  • Local and international speaker line-up of experts who are at the forefront of biotech investing and partnering
  • Professional investors looking for promising biotech investment opportunities.

 

 

Tweets by @AusBiotech